NMN: What It Is, What Research Is Studying, and What We Know
What Exactly Is NMN?
NMN stands for nicotinamide mononucleotide. That's a mouthful, so think of it this way: NMN is a small molecule your body uses as a building block to make something called NAD+.
NAD+ (nicotinamide adenine dinucleotide) is sometimes called the body's "energy currency." It sits at the center of hundreds of chemical reactions — powering your cells, helping repair DNA, and keeping a group of protective proteins called sirtuins switched on.[4] The problem? NAD+ levels can drop by up to 50% in some tissues as we age.[4] Less NAD+ has been linked to lower energy production, more oxidative stress, DNA damage, and cognitive decline.[1]
NMN is one of the most direct ways researchers know of to push NAD+ levels back up. Small amounts are even found naturally in foods like vegetables, meat, and milk — though not nearly enough to move the needle on their own.[3]
Why Are Scientists Interested in NMN?
The short answer: aging. As NAD+ falls, many hallmarks of aging seem to accelerate. Researchers are exploring whether restoring NAD+ through NMN supplementation can slow that process.[5]
Beyond basic aging biology, studies are investigating NMN's potential role in:
- Metabolic health — including blood sugar regulation and insulin sensitivity[3]
- Cardiovascular function — researchers have observed effects on endothelial (blood vessel lining) health[3]
- Brain health — NMN is being studied in the context of neurodegeneration and axon (nerve fiber) protection[6]
- Physical performance — walking capacity and muscle endurance have been measured in human trials[2]
- Inflammation — preclinical work suggests NMN may help dial down inflammatory signals[3]
What Do Human Trials Actually Show?
This is where things get interesting — and where it's important to stay honest about what we know versus what we're still learning.
One well-designed clinical trial gave 80 healthy middle-aged adults either a placebo or daily doses of 300 mg, 600 mg, or 900 mg of NMN for 60 days. All three NMN groups saw blood NAD+ levels rise significantly compared to both placebo and their own starting levels — and no safety issues were found at any dose.[2] Participants taking 600 mg or 900 mg daily walked farther on a standard six-minute walking test, and their biological age (measured by a blood-based calculator) stayed stable while the placebo group's crept upward.[2] Use our research calculator to explore how dosing variables compare across studies.
Self-reported quality of life also improved in the NMN groups.[2] That's encouraging — but 80 people over 60 days is still a small, short window. Researchers are calling for larger, longer trials.[1]
What Do Animal Studies Show?
Animal data goes further. In a rigorous mouse study, long-term NMN treatment reduced frailty, kept gene expression patterns more youthful, and improved metabolic health in males. Female mice on NMN showed an 8.5% increase in median lifespan — without any increase in cancer burden.[4] NMN also appeared to shift the gut microbiome toward bacteria associated with lower inflammation and longer life.[4]
Animal results don't automatically translate to humans, but they help researchers understand how NMN might work and what to look for in future trials.[5]
Is NMN Safe?
So far, the safety picture looks reasonable. The 60-day human trial found NMN well tolerated up to 900 mg per day, with no worrying changes in lab values or adverse events.[2] A broader review of the research literature noted that proper long-term clinical investigations are still needed before firm conclusions can be drawn.[1] As with any research compound, context and dose matter — which is why having a reference point is useful.
Where to Find the Research Dosage Chart
If you're digging into the research literature, dosing protocols vary significantly between studies. Our NMN dosage chart compiles the amounts, frequencies, and populations used across published studies so you can compare them side by side. This is for educational and research reference only — not a prescription or medical recommendation.
The science around NMN is genuinely exciting and genuinely early. Keep watching this space.
Sources
- Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns. — Journal of advanced research, 2022. PMID 35499054.
- The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. — GeroScience, 2023. PMID 36482258.
- NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health. — Current nutrition reports, 2023. PMID 37273100.
- Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner. — bioRxiv : the preprint server for biology, 2024. PMID 38979132.
- Biological properties, synthetic pathways and anti-aging mechanisms of nicotinamide mononucleotide (NMN): Research progress and challenges. — Biogerontology, 2025. PMID 40550930.
- NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies. — Neuroscience research, 2023. PMID 36657725.